Docket Room.
A 5784·NJ·house

Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

In CommitteeFiled Nov 16, 2026
Sponsor: Roy Freiman (D)
Latest Action

Introduced First Reading Assembly Referred to AFI

Nov 16, 2026

Email me when A 5784 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track A 5784. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill requires any pharmacist or the pharmacist’s designee to notify the consumer when the medication they receive is a substitute for the prescribed drug or biological product. It applies to all pharmacy transactions in New Jersey and is intended to increase transparency for patients about what they are taking.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about A 5784

3 free questions a day, no account

Sponsors

  • Roy Freiman (D) · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when A 5784 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track A 5784 free

Or ask your AI assistant about A 5784 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice